ETRAVIRINE 100 mg/1
ETRAVIRINE · TABLET · Leading Pharma, LLC
Etravirine is a prescription tablet taken by mouth to help treat Human Immunodeficiency Virus (HIV) infection by blocking reverse transcriptase, an enzyme the virus needs to replicate. It is typically used as part of a combination antiretroviral therapy regimen for HIV-positive patients.
Key Facts
- Brand Name
- ETRAVIRINE
- Generic Name
- ETRAVIRINE
- NDC Code (Product)
69315-285- Manufacturer
- Leading Pharma, LLC
- Strength
- 100 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA215402
- Drug Class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 06/05/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is ETRAVIRINE used for?
Etravirine is a prescription tablet taken by mouth to help treat Human Immunodeficiency Virus (HIV) infection by blocking reverse transcriptase, an enzyme the virus needs to replicate. It is typically used as part of a combination antiretroviral therapy regimen for HIV-positive patients.
Is ETRAVIRINE a controlled substance?
ETRAVIRINE is not classified as a controlled substance by the DEA.
What is the generic name for ETRAVIRINE?
The generic name for ETRAVIRINE is ETRAVIRINE. There are 9 other brand versions of ETRAVIRINE.
What is the NDC code for ETRAVIRINE 100 mg/1?
The NDC (National Drug Code) for ETRAVIRINE 100 mg/1 is 69315-285, listed by Leading Pharma, LLC.